FIELD: medicine. SUBSTANCE: method involves determination of lipoprotein level in whole blood serum in the presence of 4-6% polyethylene glycol solution. Mixture is incubated for 3-5 min. and light transmission is recorded and at value 73.6 ± 1.05 the presence of oxidized lipoproteins is determined in serum. EFFECT: improved method of analysis. 5 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR RAPID DETERMINATION OF RESISTANCE TO LDL OXIDATION OF HUMAN SERUM | 2015 |
|
RU2578027C1 |
METHOD FOR SELECTION AND STUDY OF ATHEROGENICITY OF IMMUNE COMPLEXES CONTAINING MULTIPLE MODIFIED LIPOPROTEINS | 2016 |
|
RU2632118C1 |
MEDIUM AND METHOD FOR DETECTION OF MULTIPLY MODIFIED BLOOD SERUM LIPOPROTEINS | 2010 |
|
RU2444014C1 |
METHOD FOR SEPARATION AND QUANTITATIVE DETERMINATION OF MULTIPLY MODIFIED LOW-DENSITY LIPOPROTEINS | 2015 |
|
RU2592238C1 |
METHOD FOR DETERMINING RESISTANCE TO LOW DENSITY BLOOD SERUM LIPOPROTEIN OXIDATION | 1997 |
|
RU2151403C1 |
METHOD FOR ASSESSING CHARACTER OF AUTOIMMUNE REACTION OF HUMAN BODY TO MULTIPLE MODIFIED LOW-DENSITY LIPOPROTEINS IN LYTIC TEST | 2017 |
|
RU2680848C1 |
METHOD FOR DETERMINING MINIMUM MODIFIED LIPOPROTEINS OF LOW DENSITY IN SERUM OR PLASMA OF HUMAN BLOOD | 2012 |
|
RU2501013C1 |
METHOD FOR INSTANT DETERMINATION OF BLOOD ATHEROGENICITY (VERSIONS) | 2010 |
|
RU2437098C1 |
STRAIN OF HYBRID CULTURED CELLS OF THE ANIMAL MUS MUSCULUS L AS THE PRODUCER OF MONOCLONAL ANTIBODIES AGAINST MYOGLOBIN | 0 |
|
SU1682389A1 |
METHOD FOR DETERMINATION OF BENZODIAZEPINE IN THE BLOOD SERUM AND INCUBATION MEDIUM FOR ITS REALIZATION | 0 |
|
SU1737338A1 |
Authors
Dates
1996-06-27—Published
1992-05-20—Filed